Page 87 - பார்வையாளர் ஆராய்ச்சி அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scaling up vaccine production Updated: Updated: April 12, 2021 23:07 IST There are several legal means that the government should employ to scale up production of COVID-19 vaccines Share Article AAA A health worker showing COVID-19 vaccine at a dispensary in New Delhi.   | Photo Credit: Shiv Kumar Pushpakar There are several legal means that the government should employ to scale up production of COVID-19 vaccines The precarious second wave of COVID-19 infections has hit India with greater ferocity than the first. Despite a year to prepare, we have been caught woefully off guard again. Multiple reports of the scarcity of COVID-19 vaccines and drugs have surfaced from different parts of the country. According to the Observer Research Foundation, till the end of March, India had produced 316 million doses of Covishield and Covaxin the two COVID-19 vaccines in use in India. Of this, 64.5 million doses have been exported. This suggests that the issue isn’t vaccine producti

New delhiPrabhash ranjanObserver research foundationNational institute of virologyAsian universityIndian council of medical researchSerum institute of indiaHaffkine biopharmaceutical corporationEpidemic diseases actCosmetics actBharat biotechPatents actIndian councilMedical researchNational institutePrincipal lawyer